Dr. Hakki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3181 SW Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-494-7735Fax+1 503-494-4264
Education & Training
- University of WashingtonFellowship, Infectious Disease, 2000 - 2003
- University of MichiganResidency, Internal Medicine, 1997 - 2000
- Lewis Katz School of Medicine at Temple UniversityClass of 1997
Certifications & Licensure
- OR State Medical License 2009 - 2025
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Publications & Presentations
PubMed
- Role of R5 Pyocin in the Predominance of High-RiskIsolates.Liyang Zhang, Qi Xu, Filemon C Tan, Yanhan Deng, Morgan Hakki
Biorxiv. 2024-10-07 - 1 citationsCefiderocol heteroresistance associated with mutations in TonB-dependent receptor genes inof clinical origin.Stephanie L Egge, Samie A Rizvi, Shelby R Simar, Manuel Alcalde, Jose R W Martinez
Antimicrobial Agents and Chemotherapy. 2024-08-07 - The impact of an intervention to reduce dispersal from wastewater drain sites on carbapenem-resistantcolonization and bloodstream infection on a hematopoietic cell tra...Lauren Fontana, Morgan Hakki, Egon A Ozer, Amy Laird, Lynne Strasfeld
Infection Control and Hospital Epidemiology. 2024-07-01
Press Mentions
- OHA Suggesting People Who Contract COVID-19 Seek Out Monoclonal Antibodies TreatmentSeptember 21st, 2021
- New Regional Collaborations Will Accelerate Innovation in Data-Intensive Medical ScienceNovember 5th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: